Investor Alert

New York Markets Open in:

Deciphera Pharmaceuticals Inc.

NAS: DCPH

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Oct 15, 2021, 7:12 p.m.

/zigman2/quotes/203556943/composite

$

35.00

Change

+0.17 +0.49%

Volume

Volume 7,972

Quotes are delayed by 20 min

/zigman2/quotes/203556943/composite

Previous close

$ 34.69

$ 34.83

Change

+0.14 +0.40%

Day low

Day high

$34.12

$35.70

Open

52 week low

52 week high

$26.20

$68.40

Open

Matthew L. Sherman

Currently, Matthew L. Sherman holds the position of Chief Medical Officer & Executive Vice President at Deciphera Pharmaceuticals, Inc. Dr. Sherman is also on the board of Pulmatrix Operating Co., Inc. and Pieris Pharmaceuticals, Inc. and Member-Alumni Council at Geisel School of Medicine.

He previously held the position of Chief Medical Officer & Executive Vice President at Acceleron Pharma, Inc., Professor at The Brigham & Women's Hospital, Inc., Chief Medical Officer & Senior Vice President at Synta Pharmaceuticals Corp., Therapeutic Area Director-Oncology at Genetics Institute LLC, Therapeutic Area Director-Oncology at Wyeth Pharmaceuticals LLC, Assistant Clinical Professor at Dana-Farber Cancer Institute, Inc., Member of The Marine Biological Laboratory and Assistant Clinical Professor at Harvard Medical School.

Matthew L. Sherman received an undergraduate degree from Massachusetts Institute of Technology and a doctorate from Dartmouth Medical School.

Transactions

Date Shares Transaction Value
10/04/2021 2,659   Disposition at $33.17 per share. 88,200
02/16/2021 11,100   Award at $0 per share. 0
02/16/2021 132   Disposition at $48.87 per share. 6,451
12/09/2020 207   Derivative/Non-derivative trans. at $34.43 per share. 7,127
11/16/2020 2,697   Derivative/Non-derivative trans. at $34.43 per share. 92,857
10/02/2020 2,632   Derivative/Non-derivative trans. at $51.15 per share. 134,627
02/18/2020 1,760   Award at $0 per share. 0
10/15/2019 35,000   Award at $0 per share. 0

Officers and Executives

Mr. Steven L. Hoerter
President, Chief Executive Officer & Director
Mr. Thomas P. Kelly
Chief Financial Officer, Treasurer & Executive VP
Dr. Matthew L. Sherman
Chief Medical Officer & Executive Vice President
Dr. Daniel L. Flynn
Chief Scientific Officer & Executive VP
Dr. Stephen B. Ruddy
Chief Technical Officer
Mr. Eric Haltom
Senior Vice President-Clinical Operations
Mr. Daniel C. Martin
Chief Commercial Officer
Ms. Jennifer Robinson
Head-Investor Relations
Ms. Caroline Chevalier
Vice President-Human Resources
Mr. Jeffrey M. Held
General Counsel & Senior Vice President
Mr. Jama Pitman
Vice President-Regulatory & Quality Assurance
Dr. James A. Bristol
Chairman
Dr. Susan L. Kelley
Independent Director
Mr. Ron Squarer
Independent Director
Mr. Franklin S. Friedman
Independent Director
Ms. Patricia L. Allen
Independent Director
Dr. Edward J. Benz
Independent Director
Mr. John R. Martin
Independent Director
Mr. Dennis L. Walsh
Independent Director
Link to MarketWatch's Slice.